Press release
Rising Prevalence Of Alzheimer's Disease To Drive Market Growth: A Key Driver Powering Alzheimer's Drugs Market Growth In 2025
Alzheimer's Drugs
What Is the Current Alzheimer's Drugs Market Size and Its Estimated Growth Rate?
The market size for Alzheimer's medication has seen robust expansion in the past few years. Forecasts predict an increase from $9.33 billion in 2024 to $10.19 billion by 2025, marking a compound annual growth rate (CAGR) of 9.1%. The growth witnessed in the historical period can be tied to an uptick in Alzheimer's disease cases, sustained funding in scientific investigation and development, a deeper comprehension of disease mechanisms, internationally coordinated health programs, and increased public awareness and education.
The market size for Alzheimer's medications is projected to experience robust growth over the next few years, increasing to approximately $14.47 billion in 2029 with a compound annual growth rate (CAGR) of around 9.2%. This predicted growth during the forecast period can be connected to the adoption of precision medicine approaches, attention given to disease modification, the identification and validation of biomarkers, patient-centric drug design, and the focus on non-pharmaceutical interventions. Major market trends for the forecast period include varied therapeutic tactics, digital health tools, regenerative medicine, breakthroughs in diagnostic technologies, the use of artificial intelligence (AI) in the development of new medications, and strategic partnerships and collaborations.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9040
How Are Emerging Segments Shaping the Alzheimer's Drugs Market Landscape?
The alzheimer's drugs market covered in this report is segmented -
1) By Drugs: Donepezil, Rivastigmine, Galantamine, Memantine
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Application: Early To Moderate Stages, Moderate To Severe Stages
Subsegments:
1) By Donepezil: Oral Tablets, Oral Solution
2) By Rivastigmine: Oral Capsules, Oral Solution, Transdermal Patches
3) By Galantamine: Oral Tablets, Oral Solution, Extended-Release Capsules
4) By Memantine: Oral Tablets, Oral Solution, Extended-Release Capsules
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9040&type=smp
Which Growth Factors Are Influencing Alzheimer's Drugs Market Expansion?
The anticipated escalation in cases of Alzheimer's disease is likely to drive the Alzheimer's drugs market's growth. Alzheimer's disease, a progressive neurological disorder, leads to shrinkage of the brain and cell death over time. Drugs designed to treat Alzheimer's focus on addressing memory loss, difficulty with cognitive processes, and the challenges of day-to-day living. Such Alzheimer's drugs can significantly improve patients' quality of life and help them maintain their independence. For example, a report by the Alzheimer's Association, a US nonprofit organization in Alzheimer's care, support, and research, in May 2024 revealed an increase in Alzheimer's dementia cases among Americans aged 65 and above from 6.5 million in 2022 to a projected 6.9 million in 2024. Consequently, the rising incidence of Alzheimer's is fueling the expansion of the Alzheimer's drugs market.
Who Are the Dominant Players Across Different Alzheimer's Drugs Market Segments?
Major companies operating in the alzheimer's drugs market include AbbVie Inc., Daiichi Sankyo Company Limited, F Hoffmann-La Roche AG, Merck & Co Inc., Novartis AG, Biogen Inc., AstraZeneca PLC, Eisai Co Ltd., Eli Lilly and Company, H Lundbeck A/S, Pfizer Inc., Allergan PLC., Johnson & Johnson, Lupin Pharmaceuticals Inc., Actiza Pharmaceutical Private Limited, Neurotrope Inc., AC Immune SA, Adamas Pharmaceuticals Inc, Alzheon Inc., Anavex Life Sciences Corp, Axsome Therapeutics Inc., Cassava Sciences Inc., Cognition Therapeutics Inc., Cortexyme Inc., Denali Therapeutics Inc, EIP Pharma Inc., Enlivex Therapeutics Ltd., FORUM Pharmaceuticals Inc., Genentech Inc., Green Valley Pharmaceuticals LLC, Intra-Cellular Therapies Inc., Karuna Therapeutics Inc., Neurim Pharmaceuticals Ltd
What Are the Latest Developing Trends in the Alzheimer's Drugs Market?
Leading firms in the Alzheimer's drugs industry are concentrating on the creation of novel products, such as therapies that target amyloid plaque, to improve treatments and patient recovery. The amyloid plaque-targeting therapy is a treatment strategy for Alzheimer's disease that aims to decrease or inhibit the buildup of amyloid-beta plaques in the brain. For example, in June 2024, Eli Lilly and Company, a pharmaceutical company based in the US, received the approval for Kisunla (donanemab-azbt) from the Food and Drug Administration (FDA), the US federal agency responsible for public health protection. Kisunla (donanemab-azbt) stands out as the first and only treatment focusing on amyloid plaque for the early symptomatic phase of Alzheimer's disease. It functions by assisting the body in eliminating excess amyloid plaques from the brain connected with cognitive deterioration in Alzheimer's patients. Kisunla is given as an intravenous infusion every four weeks. The initial dose includes 700 mg for the initial three doses, followed by 1400 mg for subsequent doses. Kisunla is specifically recommended for adults with mild cognitive impairment (MCI) and minor Alzheimer's disease dementia stages, only if they have confirmed amyloid pathology.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/alzheimers-drugs-global-market-report
Which Geographic Regions Are Expected to Dominate the Alzheimer's Drugs Market in the Coming Years?
North Americawas the largest region in the Alzheimer's drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the Alzheimer's drugs market during the forecast period. The regions covered in the Alzheimer's drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Alzheimer's Drugs Market?
2. What is the CAGR expected in the Alzheimer's Drugs Market?
3. What Are the Key Innovations Transforming the Alzheimer's Drugs Industry?
4. Which Region Is Leading the Alzheimer's Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Alzheimer's Disease To Drive Market Growth: A Key Driver Powering Alzheimer's Drugs Market Growth In 2025 here
News-ID: 3976898 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Alzheimer
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…
